Loading…
Loading…
a2 Milk (ASX:A2M) is a premium dairy company whose China infant formula business drives fund manager sentiment. In August 2026, Pendal Group said the FY26 result was in line, but FY27 guidance came in about 6% below expectations as earnings were pushed out after a supply chain disruption, leading to downgrades. Paradice and Cadence Capital see the share price fall as temporary, and Ausbil rated a2 Milk a buy, arguing China's birth rate may have bottomed as marriages rise, with Paradice increasing its position on conviction in brand strength and market share gains. Pendal also noted a $300 million special dividend after Chinese regulatory approval for new China Label registrations. a2 Milk operates in the Consumer Staples sector within the Food Products industry, and Thesis Tracker has captured 49 comments from 14 fund managers, including Pendal Group, Paradice, Cadence and Ausbil. Founded in 2000 and headquartered in Auckland, a2 Milk sells milk and infant formula containing only A2 beta-casein protein in China, Australia, New Zealand and the US.
Company figures as of 15 Oct 2026. For information only.
Fund managers including Ten Cap, Milford Asset Management, Antares Capital, Perpetual Asset Management, Wilson Asset Management, Pendal Group, Mint Asset Management, Ausbil Investment Management, Alphinity Investment Management, Paradice Investment Management, Ellerston Capital, Solaris Investment Management, Firetrail Investments and Cadence Capital have invested in A2 Milk Company Ltd (ASX:A2M).
Paradice highlights brand strength and market share gains in China infant formula, increasing its position after weakness, while Pendal notes a $300 million special dividend following regulatory approval for China Label registrations acquired with the Pokeno facility. Cadence sees the correction as reflecting temporary headwinds, and Ausbil points to double-digit growth in Chinese marriages, which typically lead births by about 12 months, along with continued market share gains.
Pendal points to softer FY27 guidance as earnings are delayed by six to 12 months due to a supply chain disruption, driving outer-year downgrades, and Paradice notes near-term China infant formula channel dynamics weighed on the shares. Lower Chinese birth rates remain a key debate, though Ausbil believes they may have bottomed.
The a2 Milk Co. Ltd. distributes and sells premium milk and dairy products. Founded in 2000 and headquartered in Auckland, New Zealand, the company operates across four key segments: Australia and New Zealand, China and Other Asia, the USA, and Mataura Valley Milk. Revenue is generated through infant formula, dairy products, manufacturing, and international licensing fees. The Australia and New Zealand segment focuses on retail and royalties, while China and Other Asia center on exports. The USA segment reports milk sales and licenses, and Mataura Valley Milk specializes in nutritional and commodity product manufacturing.
General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.